Profile
International Journal of Surgery & Surgical Procedures Volume 1 (2016), Article ID 1:IJSSP-106, 4 pages
https://doi.org/10.15344/2456-4443/2016/106
Review Article
Alkaptonuria and Ochronosis

Jozef Rovenský1*, Richard Imrich2 and Tibor Urbánek1

1National Institute of Rheumatic Disease, Piestany, Slovakia
2Biomedical Research Centre, Bratislava, Slovakia
Prof. Jozef Rovenský, National Institute of Rheumatic Disease, Piestany, Slovakia; E-mail: jozef.rovensky@nurch.sk
28 May 2016; 28 July 2016; 30 July 2016
Rovenský J, Imrich R, Urbánek T (2016) Alkaptonuria and Ochronosis. Int J Surg Surgical Proced 1: 106. doi: https://doi.org/10.15344/2456-4443/2016/106

References

  1. Kann MG (2010) Advances in translational bioinformatics: computational approaches for the hunting of disease genes. Brief Bioinform 11: 96-110. View
  2. Garrod AE (1909) Inborn Errors of metabolism. Frowde, Hoder and Stoughton, London.
  3. Ladu BN, Zannoni VG, Laster L, Seegmiller JE (1958) The nature of the defect in tyrosine metabolism in alcaptonuria. J Biol Chem 230: 251-260. View
  4. Pollak MR, Chou YH, Cerda JJ, Steinmann B, La Du BN, et al. (1993) Homozygosity mapping of the gene for alkaptonuria to chromosome 3q2. Nat Genet 5: 201-204. View
  5. Skinsnes OK (1948) Generalized ochronosis: Report of an instance in which it was misdiagnozed as melanosarcoma, with resultant enucleation of an eye. Arch Pathol (Chic) 45: 552-558. View
  6. Brunner H (1929) Über die Veränderungen des Schläfenbeines bei der Ochronose. Uschr Ohrenheilk 63: 997-1007.
  7. Hüttl S, Markovic O, Sitaj S (1966) [Hemarthrosis in ochronotic arthropathy]. Z Rheumaforsch 25: 169-181. View
  8. Sitaj Š, Lagier R (1973) Arthtopatia ochronotica. Acta Rheum Balneol Pist 7: 1-120.
  9. Cervenansky J, Sitaj S, Urbanek T (1959) Alkaptonuria and ochronosis. J Bone Joint Surg Am 41-41A: 1169-82. View
  10. Barel J, Bamatter F, Courvoisier B (1960) Troubles familiaux du metabolisme des acides aminés (alcaptonurie, oligophrénie phénylpyruvique, cataracte congenitale dans une méme famille) Schweiz Med Wchschr 90: 863-875.
  11. Urbanek T, SITAJ S (1955) Simultaneous occurrence of alkaptonuria, ochronotic arthropathy and Bechterew's disease. Fysiatr Vestn Cesk Fysiatr Spol 33: 85-91. View
  12. Kihara T, Yasuda M, Watanabe H, Suenaga Y, Shiokawa S, et al. (1994) Coexistence of ochronosis and rheumatoid arthritis. Clin Rheumatol 13: 135-138. View
  13. Anderson B (1947) Corneal and conjunctival pigmentation among workers engaged in manufacture of hydroquinone. Arch Ophthal 38: 812-826. View
  14. Sugar HS, Waddell WW (1946) Ochronosis-like pigmentation associated with the use of atabrine. Ill Med J 89: 234-239. View
  15. Ranganath LR, Jarvis JC, Gallagher JA (2013) Recent advances in management of alkaptonuria (invited review; best practice article). J Clin Pathol 66: 367-373. View
  16. Introne WJ, Perry MB, Troendle J, Tsilou E, Kayser MA, et al. (2011) A 3-year randomized therapeutic trial of nitisinone in alkaptonuria. Mol Genet Metab 103: 307-314. View
  17. Ranganath LR, Milan AM, Hughes AT, Dutton JJ, Fitzgerald R3, et al. (2016) Suitability Of Nitisinone In Alkaptonuria 1 (SONIA 1): an international, multicentre, randomised, open-label, no-treatment controlled, parallelgroup, dose-response study to investigate the effect of once daily nitisinone on 24-h urinary homogentisic acid excretion in patients with alkaptonuria after 4 weeks of treatment. Ann Rheum Dis 75: 362-367. View